Skip to content

A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate

A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02195245
Enrollment
20
Registered
2014-07-21
Start date
2014-08-31
Completion date
2014-10-31
Last updated
2016-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CO2 Removal, End Tidal CO2

Keywords

CO2 filter, anesthesia, device

Brief summary

CO2 removal is a mandatory part of modern anesthesia systems. Current chemical absorbers pose problems as the chemical granulate reacts not only with the CO2 but also the anesthetic drugs, producing organ toxic substances. The proposed CO2 absorber provides a solution to the problem of organ-toxin production in anesthetic circuits.

Detailed description

CO2 removal is a mandatory part of modern anesthesia systems. Current chemical absorbers pose problems as the chemical granulate reacts not only with the CO2 but also the anesthetic drugs, producing organ toxic substances. The proposed CO2 absorber provides a solution to the problem of organ-toxin production in anesthetic circuits. This new absorber can be easily integrated into any anesthesia circuit, and can effectively remove CO2 without reacting with anesthetic drugs, thus eliminating organ-toxic by-products. It uses advanced membrane technology to separate gas flows within the circuit, separating the expensive anesthetic vapors from the CO2 (the main by-product of metabolism). Anesthetic vapors thus remain in the closed loop circuit, while CO2 is separated and exhausted to the atmosphere, rather than being absorbed through a chemical reaction.

Interventions

DEVICEmemsorb

Sponsors

DMF Medical Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiology Physical Status Class I, II, III (low-medium risk patient) * English-speaking patients * Scheduled for elective surgery * Length of anesthesia ≥ 60 minutes

Exclusion criteria

* Pregnant * American Society of Anesthesiology Physical Status Class IV (high risk patient) * Patients schedule for emergency surgery * Known respiratory disease, including COPD and severe asthma * Have elevated pressure in your brain (intra cranial pressure, ICP)

Design outcomes

Primary

MeasureTime frameDescription
End tidal CO2 levelContinuous (5min intervals) over duration of anesthesia. No data collection prior or post anesthesia.After completion of the surgery, the digital respiration records are exported from the hospital database. End tidal CO2 is assessed as either in range \[4.1-5.6\]% or out of range \<4.1% or \>5.6%.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026